Schistosoma mansoni schistosomula tegument (Smteg) immunization in absence of adjuvant induce IL-10 production by CD4+ cells and failed to protect mice against challenge infection

Acta Trop. 2012 Nov;124(2):140-6. doi: 10.1016/j.actatropica.2012.07.007. Epub 2012 Jul 27.

Abstract

The Schistosoma mansoni tegument interaction with the immune system plays a key role in disease establishment or elimination. We have recently demonstrated that S. mansoni schistosomula tegument (Smteg) is able to activate innate immune response and to induce protective immunity in a vaccine formulation with Freunds adjuvant. In this work, we evaluated the ability of Smteg to elicit protection in the absence of adjuvant. Smteg mice immunization resulted in significant antibody production, increased percentage of CD4+IFN-g+ and CD4+IL-10+ cells in spleen and increased production of IFN-g and IL-10 by spleen cells, but failed to reduce parasite burden, female fecundity and morbidity. We also demonstrated that BMDC stimulation with Smteg resulted in significant IL-10 production. Our results demonstrate that Smteg has immune modulatory proprieties.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Helminth / blood
  • Antigens, Helminth / administration & dosage
  • Antigens, Helminth / immunology
  • CD4-Positive T-Lymphocytes / immunology*
  • Female
  • Fertility / immunology
  • Helminth Proteins / administration & dosage
  • Helminth Proteins / immunology*
  • Immunization / methods*
  • Interferon-gamma / metabolism
  • Interleukin-10 / metabolism*
  • Mice
  • Mice, Inbred C57BL
  • Parasite Load
  • Schistosoma mansoni / immunology*
  • Schistosomiasis mansoni / prevention & control*
  • Vaccines / administration & dosage
  • Vaccines / immunology*

Substances

  • Antibodies, Helminth
  • Antigens, Helminth
  • Helminth Proteins
  • IL10 protein, mouse
  • Vaccines
  • Interleukin-10
  • Interferon-gamma